A Through QT/QTc Study of KW-6356

NCT04342273 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6356
DRUG: KW-6356
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Kyowa Kirin Co., Ltd.